DrugPatentWatch Database Preview
Valeant Company Profile
What is the competitive landscape for VALEANT, and when can generic versions of VALEANT drugs launch?
VALEANT has one hundred and twenty-five approved drugs.
There are forty-three US patents protecting VALEANT drugs.
There are two hundred and seventy-one patent family members on VALEANT drugs in forty-six countries and seventy-seven supplementary protection certificates in fourteen countries.
Summary for Valeant
| International Patents: | 271 |
| US Patents: | 43 |
| Tradenames: | 102 |
| Ingredients: | 80 |
| NDAs: | 125 |
| Patent Litigation for Valeant: | See patent lawsuits for Valeant |
Drugs and US Patents for Valeant
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharms Intl | UCERIS | budesonide | TABLET, EXTENDED RELEASE;ORAL | 203634-001 | Jan 14, 2013 | AB | RX | Yes | Yes | 8,293,273 | ➤ Sign Up | Y | ➤ Sign Up | ||
| Valeant Pharms North | DIASTAT ACUDIAL | diazepam | GEL;RECTAL | 020648-007 | Sep 15, 2005 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Valeant Intl | ATIVAN | lorazepam | TABLET;ORAL | 017794-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ||||
| Valeant Pharms Intl | GIAZO | balsalazide disodium | TABLET;ORAL | 022205-001 | Feb 3, 2012 | AB | RX | Yes | Yes | 8,497,256 | ➤ Sign Up | ➤ Sign Up | |||
| Valeant Pharms Intl | APRISO | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 022301-001 | Oct 31, 2008 | RX | Yes | Yes | 8,956,647 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Valeant Pharms North | ISORDIL | isosorbide dinitrate | TABLET;ORAL | 012093-006 | Jul 29, 1988 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Valeant
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Valeant Pharms | ULTRAM ER | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021692-001 | Sep 8, 2005 | 7,074,430 | ➤ Sign Up |
| Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | 4,603,146 | ➤ Sign Up |
| Valeant Pharm Intl | DALMANE | flurazepam hydrochloride | CAPSULE;ORAL | 016721-001 | Approved Prior to Jan 1, 1982 | 4,316,897 | ➤ Sign Up |
| Valeant Pharms Intl | COLAZAL | balsalazide disodium | CAPSULE;ORAL | 020610-001 | Jul 18, 2000 | 4,412,992*PED | ➤ Sign Up |
| Valeant Pharm Intl | ZELAPAR | selegiline hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021479-001 | Jun 14, 2006 | 6,423,342 | ➤ Sign Up |
| Valeant Pharms North | DIASTAT | diazepam | GEL;RECTAL | 020648-004 | Jul 29, 1997 | 5,462,740 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for VALEANT drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Rectal Gel | 2.5 mg/0.5 mL, 5 mg/mL, 10 mg/2 mL, 15 mg/3 mL and 20 mg/4 mL | ➤ Subscribe | 2004-03-23 |
| ➤ Subscribe | Rectal Gel | 5 mg/mL, 2mL pre-filled syringe | ➤ Subscribe | 2008-12-23 |
| ➤ Subscribe | Gel | 0.04% | ➤ Subscribe | 2010-12-20 |
| ➤ Subscribe | Extended-release Tablets | 348 mg | ➤ Subscribe | 2009-09-24 |
| ➤ Subscribe | Extended-release Tablets | 420 mg | ➤ Subscribe | 2005-04-25 |
| ➤ Subscribe | Capsules | 75 mg | ➤ Subscribe | 2011-06-06 |
| ➤ Subscribe | Extended-release Tablets | 100 mg | ➤ Subscribe | 2007-01-08 |
| ➤ Subscribe | Extended-release Tablets | 300 mg | ➤ Subscribe | 2007-09-25 |
| ➤ Subscribe | Extended-release Capsules | 0.375 g | ➤ Subscribe | 2012-04-03 |
| ➤ Subscribe | Cream | 0.5% | ➤ Subscribe | 2011-07-29 |
| ➤ Subscribe | Rectal Gel | 5 mg/mL, 4mL pre-filled syringe | ➤ Subscribe | 2008-12-08 |
| ➤ Subscribe | Gel | 0.1% | ➤ Subscribe | 2010-07-08 |
| ➤ Subscribe | Extended-release Tablets | 174 mg | ➤ Subscribe | 2009-09-28 |
| ➤ Subscribe | Extended-release Tablets | 120 mg, 180 mg, 240 mg, 300 mg and 360 mg | ➤ Subscribe | 2005-08-30 |
| ➤ Subscribe | Extended-release Tablets | 522 mg | ➤ Subscribe | 2009-12-24 |
| ➤ Subscribe | Extended-release Tablets | 150 mg and 300 mg | ➤ Subscribe | 2004-09-21 |
| ➤ Subscribe | For Inhalation Solution | 6 gm/vial | ➤ Subscribe | 2014-05-22 |
| ➤ Subscribe | Extended-release Tablets | 200 mg | ➤ Subscribe | 2007-03-28 |
| ➤ Subscribe | Extended-release Tablets | 9 mg | ➤ Subscribe | 2013-03-11 |
| ➤ Subscribe | Tablets | 1.1 g | ➤ Subscribe | 2013-11-05 |
Premature patent expirations for VALEANT
International Patents for Valeant Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2219181 | ➤ Sign Up |
| South Korea | 20090118906 | ➤ Sign Up |
| Malaysia | 118718 | ➤ Sign Up |
| Italy | MI991317 | ➤ Sign Up |
| Australia | 772435 | ➤ Sign Up |
| Japan | 2001506279 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Valeant Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1304992 | C01304992/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014 |
| 0328535 | 96C0021 | Belgium | ➤ Sign Up | PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209 |
| 1539166 | 13C0062 | France | ➤ Sign Up | PRODUCT NAME: (A) DEXTROMETHORPHAN OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE, PAR EXEMPLE LE BROMHYDRATE DE DEXTROMETHORPHAN ET EN PARTICULIER LE MONOHYDRATE DE BROMHYDRATE DE DEXTROMETHORPHAN (B) QUINIDINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE, PAR EXEMPLE LE SULFATE DE QUINIDINE EN PARTICULIER LE DIHYDRATE DE SULFATE DE QUINIDINE; REGISTRATION NO/DATE: EU/1/13/833/001-003 20130626 |
| 0809498 | SPC/GB10/012 | United Kingdom | ➤ Sign Up | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| 0237929 | SPC/GB97/088 | United Kingdom | ➤ Sign Up | PRODUCT NAME: TOLCAPONE; REGISTERED: CH 54055/01 19970225; CH 54055/02 19970225; UK EU/1/97/044/001 19970827; UK EU/1/97/044/002 19970827; UK EU/1/97/044/003 19970827; UK EU/1/97/044/004 19970827; UK EU/1/97/044/005 19970827; UK EU/1/97/044/006 19970827 |
| 1586316 | SPC/GB11/054 | United Kingdom | ➤ Sign Up | PRODUCT NAME: BROMFENAC 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF OR A HYDRATE THEREOF; REGISTERED: UK EU/1/11/692/001 20110523 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
